SEC recommendations on Covaxin emergency use authorisation for 2-18 age group being examined: Government

The CDSCO has also approved COVID-19 vaccine (ZyCoV-D) of Cadila Healthcare for restricted use in emergency situation in the age group 12 years and above.



Source link